Seung Hoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seung Hoon Kim has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Dongil Choi
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea
6 shared publications- Won Jae Lee
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
5 shared publications Hyo Keun Lim
Sungkyunkwan University School of Medicine
4 shared publications- Jae Hoon Lim
Myongji Hospital
3 shared publications Soon Jin Lee
Sungkyunkwan University School of Medicine
3 shared publications- Hyo Keun Lim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2008
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 58 (1) , 53-63
Comparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis
Jeon YH, et al. J Korean Radiol Soc. 2008 Jan;58(1):53-63. https://doi.org/10.3348/jkrs.2008.58.1.53
- 1 January 2008
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 58 (1) , 53-63
Open AccessComparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis
Jeon YH, et al. J Korean Radiol Soc. 2008 Jan;58(1):53-63. https://doi.org/10.3348/jkrs.2008.58.1.53
- 17 January 2006
- Published by Springer Nature in European Radiology
- Vol. 16 (5) , 972-980
Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging
The purpose of this study was to evaluate the accuracy of 3-Tesla magnetic resonance imaging (MRI) for the preoperative staging of rectal cancer. Thirty-five patients with a primary rectal cancer who underwent preoperative 3-T MRI using a phased-array coil and had a surgical resection were enrolled in the study group. Preoperatively, three experienced radiologists independently assessed the T and N staging. A confidence level scoring system was used to determine if there was any perirectal invasion, and receiver operating characteristic (ROC) curves were generated. The interobserver agreement was estimated using κ statistics. The overall accuracy rate of T staging for rectal cancer was 92%. The diagnostic accuracy was 97% for T1, 89% for T2 and 91% for T3, respectively. The predictive accuracy for perirectal invasion by the three observers was high (Az>0.92). The interobserver agreement for T staging was moderate to substantial. The overall sensitivity, specificity, and accuracy for the detection of mesorectal nodal metastases were 80%, 98%, and 95%, respectively. In conclusion, preoperative 3-T MRI using a phase-array coil accurately indicates the depth of tumor invasion for rectal cancer with a low variability.
- 17 January 2006
- Published by Springer Nature in European Radiology
- Vol. 16 (5) , 972-980
Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging
The purpose of this study was to evaluate the accuracy of 3-Tesla magnetic resonance imaging (MRI) for the preoperative staging of rectal cancer. Thirty-five patients with a primary rectal cancer who underwent preoperative 3-T MRI using a phased-array coil and had a surgical resection were enrolled in the study group. Preoperatively, three experienced radiologists independently assessed the T and N staging. A confidence level scoring system was used to determine if there was any perirectal invasion, and receiver operating characteristic (ROC) curves were generated. The interobserver agreement was estimated using κ statistics. The overall accuracy rate of T staging for rectal cancer was 92%. The diagnostic accuracy was 97% for T1, 89% for T2 and 91% for T3, respectively. The predictive accuracy for perirectal invasion by the three observers was high (Az>0.92). The interobserver agreement for T staging was moderate to substantial. The overall sensitivity, specificity, and accuracy for the detection of mesorectal nodal metastases were 80%, 98%, and 95%, respectively. In conclusion, preoperative 3-T MRI using a phase-array coil accurately indicates the depth of tumor invasion for rectal cancer with a low variability.
- 1 April 2005
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 184 (4) , 1069-1076
Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma
OBJECTIVE. We compared ferucarbotran-enhanced MRI with triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. SUBJECTS AND METHODS. Seventy-three consecutive patients with 121 hepatocellular carcinomas underwent ferucarbotran-enhanced MRI, including a dynamic study, and triple-phase MDCT before hepatic resection. The diagnosis of hepatocellular carcinoma was confirmed in all patients by means of pathologic examination after surgical resection. Three experienced radiologists independently reviewed the MR and CT images on a segment-by-segment basis. The accuracy of these techniques for the detection of hepatocellular carcinoma was assessed by conducting a receiver operating characteristic (ROC) analysis of the observations of 88 resected hepatic segments with at least one hepatocellular carcinoma each and 121 resected hepatic segments without hepatocellular carcinoma. RESULTS. The mean values of the area under the ROC curve (Az) for ferucarbotran-enhanced MRI and triple-phase MDCT for all observers were 0.947 and 0.949, respectively; the difference between these two values was not statistically significant (p = 0.799). The mean sensitivities of MRI and triple-phase MDCT were 90.2% and 91.3%, respectively, and their mean specificities were 97.0% and 95.3%, respectively. The differences in the mean sensitivities and specificities of these two imaging techniques were not statistically significant (p > 0.05 in each case). CONCLUSION. Ferucarbotran-enhanced MRI seems to be as accurate as triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
- 1 April 2005
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 184 (4) , 1069-1076
Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma
OBJECTIVE. We compared ferucarbotran-enhanced MRI with triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. SUBJECTS AND METHODS. Seventy-three consecutive patients with 121 hepatocellular carcinomas underwent ferucarbotran-enhanced MRI, including a dynamic study, and triple-phase MDCT before hepatic resection. The diagnosis of hepatocellular carcinoma was confirmed in all patients by means of pathologic examination after surgical resection. Three experienced radiologists independently reviewed the MR and CT images on a segment-by-segment basis. The accuracy of these techniques for the detection of hepatocellular carcinoma was assessed by conducting a receiver operating characteristic (ROC) analysis of the observations of 88 resected hepatic segments with at least one hepatocellular carcinoma each and 121 resected hepatic segments without hepatocellular carcinoma. RESULTS. The mean values of the area under the ROC curve (Az) for ferucarbotran-enhanced MRI and triple-phase MDCT for all observers were 0.947 and 0.949, respectively; the difference between these two values was not statistically significant (p = 0.799). The mean sensitivities of MRI and triple-phase MDCT were 90.2% and 91.3%, respectively, and their mean specificities were 97.0% and 95.3%, respectively. The differences in the mean sensitivities and specificities of these two imaging techniques were not statistically significant (p > 0.05 in each case). CONCLUSION. Ferucarbotran-enhanced MRI seems to be as accurate as triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
- 1 January 2004
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 230 (1) , 135-141
Recurrent Hepatocellular Carcinoma: Percutaneous Radiofrequency Ablation after Hepatectomy
PURPOSE: To evaluate the therapeutic efficacy and safety of percutaneous radiofrequency (RF) ablation for recurrent hepatocellular carcinoma (HCC) in the liver after hepatectomy.MATERIALS AND METHODS: Forty-five patients with 53 recurrent HCC tumors in the liver underwent percutaneous RF ablation with ultrasonographic guidance. All patients had a history of hepatic resection for HCC. The mean diameter of recurrent tumors was 2.1 cm (range, 0.8–4.0 cm). All patients were followed up for at least 10 months after ablation (range, 10–40 months; mean, 23 months). Therapeutic efficacy and complications were evaluated with multiphase helical computed tomography (CT) at regular follow-up visits. Overall and disease-free survival rates were calculated.RESULTS: At follow-up CT after initial RF ablation, 11 (21%) of 53 ablated HCC tumor sites showed residual tumor or local tumor progression. After additional RF ablation, complete ablation of 46 (87%) of 53 tumors was attained. Also at initial follow-up CT, before either additional RF ablation or other treatment was performed, 21 (47%) of 45 patients were found to have 41 new HCC tumors at other liver sites. Of these, nine tumors in eight patients were treatable with a second application of RF ablation. Overall survival rates at 1, 2, and 3 years were 82%, 72%, and 54%, respectively. No deaths or complications requiring further treatment occurred as a result of RF ablation.CONCLUSION: Percutaneous RF ablation is an effective and safe method for treating recurrent HCC in the liver after hepatectomy, with a good overall patient survival rate.© RSNA, 2003
- 1 January 2004
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 230 (1) , 135-141
Recurrent Hepatocellular Carcinoma: Percutaneous Radiofrequency Ablation after Hepatectomy
PURPOSE: To evaluate the therapeutic efficacy and safety of percutaneous radiofrequency (RF) ablation for recurrent hepatocellular carcinoma (HCC) in the liver after hepatectomy.MATERIALS AND METHODS: Forty-five patients with 53 recurrent HCC tumors in the liver underwent percutaneous RF ablation with ultrasonographic guidance. All patients had a history of hepatic resection for HCC. The mean diameter of recurrent tumors was 2.1 cm (range, 0.8–4.0 cm). All patients were followed up for at least 10 months after ablation (range, 10–40 months; mean, 23 months). Therapeutic efficacy and complications were evaluated with multiphase helical computed tomography (CT) at regular follow-up visits. Overall and disease-free survival rates were calculated.RESULTS: At follow-up CT after initial RF ablation, 11 (21%) of 53 ablated HCC tumor sites showed residual tumor or local tumor progression. After additional RF ablation, complete ablation of 46 (87%) of 53 tumors was attained. Also at initial follow-up CT, before either additional RF ablation or other treatment was performed, 21 (47%) of 45 patients were found to have 41 new HCC tumors at other liver sites. Of these, nine tumors in eight patients were treatable with a second application of RF ablation. Overall survival rates at 1, 2, and 3 years were 82%, 72%, and 54%, respectively. No deaths or complications requiring further treatment occurred as a result of RF ablation.CONCLUSION: Percutaneous RF ablation is an effective and safe method for treating recurrent HCC in the liver after hepatectomy, with a good overall patient survival rate.© RSNA, 2003
- Open Access
- 1 January 2002
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 47 (3) , 285-292
Well-Differentiated Hepatocellular Carcinoma: Triple-Phase Helical CT Findings
- 1 January 2002
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 47 (3) , 285-292
Open AccessWell-Differentiated Hepatocellular Carcinoma: Triple-Phase Helical CT Findings
- Open Access
- 1 January 2002
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 47 (5) , 499-506
Mangafodipir Trisodium (Mn-DPDP)-Enhanced MR Imaging of Hepatocellular Carcinoma: Correlation with Histopathological Findings
- 1 January 2002
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 47 (5) , 499-506
Open AccessMangafodipir Trisodium (Mn-DPDP)-Enhanced MR Imaging of Hepatocellular Carcinoma: Correlation with Histopathological Findings
- Open Access
- 1 January 2002
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 3 (2) , 87-97
Optimal Pulse Sequence for Ferumoxides-Enhanced MR Imaging Used in the Detection of Hepatocellular Carcinoma: A Comparative Study Using Seven Pulse Sequences
Kim SH, et al. Korean J Radiol. 2002 Apr-Jun;3(2):87-97. https://doi.org/10.3348/kjr.2002.3.2.87
- 1 January 2002
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 3 (2) , 87-97
Open AccessOptimal Pulse Sequence for Ferumoxides-Enhanced MR Imaging Used in the Detection of Hepatocellular Carcinoma: A Comparative Study Using Seven Pulse Sequences
Kim SH, et al. Korean J Radiol. 2002 Apr-Jun;3(2):87-97. https://doi.org/10.3348/kjr.2002.3.2.87
- 1 February 2001
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 176 (2) , 475-482
Preoperative Detection of Hepatocellular Carcinoma
OBJECTIVE. The purpose of this study was to compare ferumoxides-enhanced MR imaging with combined helical CT during arterial portography and CT hepatic arteriography for preoperative detection of hepatocellular carcinomas. SUBJECTS AND METHODS. Twenty patients with 30 hepatocellular carcinomas underwent ferumoxides-enhanced MR imaging and combined helical CT during arterial portography and CT hepatic arteriography. The diagnosis was established by pathologic examination after surgical resection in 18 patients and by biopsy in two. The MR protocol included fast spin-echo with two echo times, T2*-weighted fast multiplanar gradient-recalled acquisition in the steady state, proton density—weighted fast multiplanar spoiled gradient-recalled echo, and T1-weighted fast multiplanar spoiled gradient-recalled echo images. The MR images of all sequences and the paired CT during arterial portography and CT hepatic arteriography images were independently evaluated by three radiologists on a segment-by-segment basis. Diagnostic accuracy was assessed with receiver operating characteristic analysis. RESULTS. The accuracies (Az values) of ferumoxides-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography for all observers were 0.964 and 0.948, respectively. The mean sensitivities of MR imaging and CT were 93% and 91%, respectively. The differences were not statistically significant. The mean specificity of MR imaging (99%) was significantly higher than that of combined CT during arterial portography and CT hepatic arteriography (94%). CONCLUSION. Ferumoxides-enhanced MR imaging can be used successfully in place of combined CT during arterial portography and CT hepatic arteriography for the preoperative evaluation of patients with hepatocellular carcinomas.
- 1 February 2001
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 176 (2) , 475-482
Preoperative Detection of Hepatocellular Carcinoma
OBJECTIVE. The purpose of this study was to compare ferumoxides-enhanced MR imaging with combined helical CT during arterial portography and CT hepatic arteriography for preoperative detection of hepatocellular carcinomas. SUBJECTS AND METHODS. Twenty patients with 30 hepatocellular carcinomas underwent ferumoxides-enhanced MR imaging and combined helical CT during arterial portography and CT hepatic arteriography. The diagnosis was established by pathologic examination after surgical resection in 18 patients and by biopsy in two. The MR protocol included fast spin-echo with two echo times, T2*-weighted fast multiplanar gradient-recalled acquisition in the steady state, proton density—weighted fast multiplanar spoiled gradient-recalled echo, and T1-weighted fast multiplanar spoiled gradient-recalled echo images. The MR images of all sequences and the paired CT during arterial portography and CT hepatic arteriography images were independently evaluated by three radiologists on a segment-by-segment basis. Diagnostic accuracy was assessed with receiver operating characteristic analysis. RESULTS. The accuracies (Az values) of ferumoxides-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography for all observers were 0.964 and 0.948, respectively. The mean sensitivities of MR imaging and CT were 93% and 91%, respectively. The differences were not statistically significant. The mean specificity of MR imaging (99%) was significantly higher than that of combined CT during arterial portography and CT hepatic arteriography (94%). CONCLUSION. Ferumoxides-enhanced MR imaging can be used successfully in place of combined CT during arterial portography and CT hepatic arteriography for the preoperative evaluation of patients with hepatocellular carcinomas.
- Open Access
- 1 January 2001
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 44 (2) , 177-186
Ferumoxides -enhanced MR in the Detection of Hepatocellular Carcinoma: Comparison with Combined CT During Arterial Portography and CT Hepatic Arteriography
- 1 January 2001
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 44 (2) , 177-186
Open AccessFerumoxides -enhanced MR in the Detection of Hepatocellular Carcinoma: Comparison with Combined CT During Arterial Portography and CT Hepatic Arteriography